Ahmed Elkeeb, MD
Retina Specialist · Columbia, MONPI 1568648699
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,750 of the $5,524 with a category attached, or 86.0%. Boehringer Ingelheim accounts for 86.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $4,911 and has fallen 99.2% since, to $40 in 2025.
Across 28 payments — averaging $197.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$5K
- AbbVie$153
- Carl Zeiss Meditec USA, Inc.$126
- Genentech USA, Inc.$104
- Alcon$76
- NEW World Medical,inc.$63
- plus $253 from 8 others
Across 34 payments — averaging $2120.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$53K
- AbbVie$16K
- Boehringer Ingelheim International GmbH$3K
What the payments were for
- Consulting fees$4,75086%
- Food & beverage$77414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 1 | $4,750 |
| AbbVie(2 entities) | 6 | $153 |
| Carl Zeiss Meditec USA, Inc. | 1 | $126 |
| Genentech USA, Inc. | 1 | $104 |
| Alcon | 3 | $76 |
| NEW World Medical,inc. | 1 | $63 |
| Aerie Pharmaceuticals, Inc. | 4 | $62 |
| Bausch & Lomb Americas Inc. | 2 | $46 |
| Alimera Sciences, Inc. | 2 | $36 |
| Novartis | 2 | $34 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $29 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Iridex Corporation | 1 | $15 |
| Eyepoint US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUATERA 700$126
- SUSVIMO$104
How this compares
$5,524 in reported general payments places this provider in the 70th percentile of 45 retina specialist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 15 | $4,883 |
| Difluprednate | 49 | $3,780 |
| Prednisolone Acetate | 84 | $3,408 |
| Ketorolac Tromethamine | 21 | $730 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $684 |
| Prednisone | 23 | $243 |
| Brimonidine Tartrate | 31 | $210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCombigan | $153 | $4,88315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 45 retina specialist providers in Missouri.
Other retina specialist in Columbia
- Vaishnavi BalendiranColumbia$2K
- Clint KelloggColumbia$1K
- Dean HainsworthColumbia$99
- Kevin BlinderBrentwood$333K
- Aaron LeeSaint Louis$214K
- Sabin DangBrentwood$174K
- Athanasios PapakostasBrentwood$85K
- Alia DurraniBrentwood$53K
- Barton BlackorbyBrentwood$31K
- Carla TerritoFlorissant$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.